Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT03118765 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

155

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: GSP304 (tiotropium bromide) Inhalation Solution
DRUG: GSP304 Placebo Inhalation Solution
DRUG: Spiriva® Respimat® inhalation spray

Sponsor

Glenmark Specialty S.A.